China to release Japanese pharma employee jailed for espionage after 3.5 years
Times of India
A jailed Japanese pharmaceutical employee in China is expected to be released in mid-December after serving a three-and-a-half-year sentence.
A Japanese employee working for Astellas Pharma, who was imprisoned in China on espionage charges, is anticipated to be freed in mid-December and repatriated to Japan. The individual was originally detained in March 2023, indicted in August 2024, and sentenced to three years and six months in prison in July 2025. Japanese media outlets Kyodo news agency and the Yomiuri newspaper reported the expected release, citing sources familiar with the situation.
Following the sentencing, Japan's deputy chief cabinet secretary called the verdict extremely regrettable while keeping the employee's identity and affiliation confidential. Representatives from Astellas Pharma, the Japanese foreign ministry, and the Chinese embassy did not respond to requests for comment regarding the reported release.
The imprisonment of the employee contributed to diplomatic friction between Tokyo and Beijing, adding to existing tensions over security and Taiwan. Bilateral relations were further strained following comments by Japanese Prime Minister Sanae Takaichi regarding a potential military response to a Chinese attack on Taiwan, which led to travel warnings and export restrictions from Beijing.
Why it matters: The anticipated release of the imprisoned employee highlights ongoing diplomatic sensitivities and tensions between Japan and China over security and regional disputes.



